Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
Abstract
In article results pharmacoepidemiology researches on studying of knowledge of pharmacists (n=187) on safety issues medicinal and pharmacovigilance are resulted. 28 % of pharmacists have adverse drug reactions to medicines in the practice, however submit spontaneous messages only 5 % of respondents. Princi pal causes of low activity of pharmacists - a lack of time for drawing up of reports and low level of knowledge in the field of safety of medical products. 89 % of pharmacists need educational programs on pharmacovigilance
About the Authors
E. N. Tkhoseva
I.M. Sechenov First Moscow State Medical University Russian Federation
Russian Federation
Russian Federation
T. E. Morozova
I.M. Sechenov First Moscow State Medical University Russian Federation
Russian Federation
Russian Federation
I.M. Sechenov First Moscow State Medical University Russian Federation
O. A. Vartanova
I.M. Sechenov First Moscow State Medical University Russian Federation
Russian Federation
Russian Federation
S. M. Rykova
I.M. Sechenov First Moscow State Medical University Russian Federation
Russian Federation
Russian Federation
T. B. Andruschishina
I.M. Sechenov First Moscow State Medical University Russian Federation
Russian Federation
Russian Federation
D. A. Ermakov
I.M. Sechenov First Moscow State Medical University Russian Federation
Russian Federation
Russian Federation
S. M. Oshorova
City Clinical Emergency Hospital named after V.V. Angapov, Ulan-Ude
Russian Federation
Russian Federation
References
1. Федеральная служба по надзору в сфере здравоохранения и социального развития/www.roszdravn adzor.ru.
2. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observation al studies. Ann Pharmacother. 2008. Jul;42(7):1017-25. Epub 2008 Jul 1.
3. Khalili H, Mohebbi N, Hendoiee N, Keshtkar AA, Dashti-Khavidaki S. Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre- and postclinical pharmacists' intervention al study. BMJ Open. 2012 Jan 13;2:e000367. doi: 10.1136/
4. bmjopen-2011-000367. Print 2012.
5. Цветов В.М. Знания фармацевтов вопросов побочных действий лекарств / В.М. Цветов, Г.Г. Кетова // Рациональное использование лекарств: материалы Рос. науч. – практ. конф. – Пермь, 2004. - С. 352 – 35.
6. Piening S, Haaijer-Ruskamp FM, de Graeff PA, Straus SM, Mol PG. Healthcare profession als' self-reported experiences and preferences related to direct healthcare profession al communications: a survey conducted in the Netherlands. Drug Saf. 2012 Nov 1;35(11):1061-72. doi: 10.2165/11635750-000000000-00000.
7. Smith MP, Webley SD. Pharmacovigilance teaching in UK undergraduate pharmacy programmes. Pharmacoepidemiol Drug Saf. 2012 Jun 29. doi: 10.1002/pds.3311. [Epub ahead of print].
8. Берлинская декларация по фармаконадзору (31 октября – 1 ноября 2003). Международное общество лекарственных бюллетеней/ URL: http://www.isdbweb.dspace.it/pag/publications.
9. htm.
10. Федеральный закон от 12.04.2010 №61-ФЗ (ред. От 25.06.2012) «Об обращении лекарственных средств».
11. Van Grootheest A.C., de Jong-van den Berg L.T. The role of hospital and community pharmacists in pharmacovigilance. Res Cocial Adm Pharm. 2005 Mar; 1 (1):126-33.
12. Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ. Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Sag. 2006; 29(4):331-40.
13. Gedde-Dahl A, Harg P, Stenberg-Nilsen H, Buajordet M, Gran as AG, Horn AM. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway. Pharmacoepidemiol
14. Drug Saf. 2007 Sep;16(9):999-1005.
15. Oreagba IA, Ogunleye OJ, Olayemi SO. The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, south west Nigeria. Pharmacoepidemiol Drug Saf. 2010 Sep 15. [Epub ahead of print].
16. Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol. 2011 Jul;72(1):143-52. doi: 10.1111/j.1365-
17. 2011.03944.x.
18. Tabali M, Jeschke E, Bockelbrink, Witt CM, Willich SN, Ostermann T, Mattens H. Education al intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and altern ative medicine. BMC Public Health. 2009; 9: 274. Published online 2009 July 31. Doi:10.1186/1471-2458-9-274.
19. Пономарева Л. Упредить побочный эффект. Нижегородские аптеки будут включены в мониторинг безопасности ЛС [Электронный ресурс]/Л. Пономарева // Фармацевтический
20. вестник. Апрель, 2011, №15. - Режим доступа: http://www.pharmvestnik.ru/publs/staryj-arxiv-gazety/24785.html#.UqWWQ_Vbgws.
21. Отраслевой стандарт 91500.05.0007-2003 «Правила отпуска (реализации) лекарственных средств в аптечных организациях. Основные положения» (в ред. Приказов Минздравсоцразвития РФ от 23.08.2004 №92, от 13.09.2005 № 576, от 18.04.2007 №
22. , с изм., внесенными решением Верховного Суда РФ от 11.09.2003 № ГПКИ 03-607, Приказом Минздрава РФ от 30.01.2004 №31).
Review
For citations:
Tkhoseva E.N., Morozova T.E., Vartanova O.A., Rykova S.M., Andruschishina T.B., Ermakov D.A., Oshorova S.M. Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia. Safety and Risk of Pharmacotherapy. 2014;(4):29-36. (In Russ.)
Views:
609
Email this article 